Patents expiring in 2035

US 9227933

3-phenoxymethylpyrrolidine compounds

Theravance Biopharma R&D IP, LLC · Granted Tue Jan 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9226971

N-optionally substituted aryl-2-oligomer-3-alkoxypropionamides

Nektar Therapeutics · Granted Tue Jan 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9227995

Peptides

DRUG DISCOVERY LABORATORY AS · Granted Tue Jan 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9228002

Leishmania vaccine using sand fly salivary immunogen

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jan 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9228007

Recombinant human progenitor cells, engineered human thymocytes, and engineered human T cells

The Regents of the University of California · Granted Tue Jan 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9228171

Regulatory B cells (tBREGS) and their use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9228053

Polymeric alpha-hydroxy aldehyde and ketone reagents and conjugation method

Nektar Therapeutics · Granted Tue Jan 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)